Evidence map›Paper›PMID 30590741›Full record

ArticleThe Journal of infectious diseases2019

Phylogenetic Methods Inconsistently Predict the Direction of HIV Transmission Among Heterosexual Pairs in the HPTN 052 Cohort.

Rebecca Rose, Matthew Hall, Andrew D Redd, Susanna Lamers, Andrew E Barbier, Stephen F Porcella, Sarah E Hudelson, Estelle Piwowar-Manning, Marybeth McCauley, Theresa Gamble and 17 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Molecular source attribution.PLoS computational biology · 2022
    Article
  6. Using phylogenetics to infer HIV-1 transmission direction between known transmission pairs.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  7. Article
  8. Article
  9. Evaluation of Phylogenetic Methods for Inferring the Direction of Human Immunodeficiency Virus (HIV) Transmission: HIV Prevention Trials Network (HPTN) 052.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors at 16 institutions in 9 countries.

Rebecca RoseBioInfoExperts, Thibodaux, Louisiana.
Matthew HallBig Data Institute, University of Oxford, United Kingdom.
Andrew D ReddLaboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Baltimore, Maryland.
Susanna LamersBioInfoExperts, Thibodaux, Louisiana.
Andrew E BarbierBioInfoExperts, Thibodaux, Louisiana.
Stephen F PorcellaGenomics Unit, Research Technologies Section, Rocky Mountain Laboratories, Division of Intramural Research, NIAID, NIH, Hamilton, Montana.
Sarah E HudelsonDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Estelle Piwowar-ManningDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Marybeth McCauleyScience Facilitation Department, Durham, Chapel Hill, North Carolina.
Theresa GambleScience Facilitation Department, Durham, Chapel Hill, North Carolina.
Ethan A WilsonVaccine and Infectious Disease Science Division, Fred Hutchinson Cancer Research Institute, Seattle, Washington.
Johnstone KumwendaCollege of Medicine-Johns Hopkins Project, Blantyre, Malawi.
Mina C HosseinipourDepartment of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
James G HakimUniversity of Zimbabwe, Harare.
Nagalingeswaran KumarasamyYRGCARE Medical Centre, Chennai, India.
Suwat ChariyalertsakResearch Institute for Health Sciences, Chiang Mai University, Thailand.
Jose H PilottoHospital Geral de Nova Iguaçu, Rio de Janeiro, Brazil.
Beatriz GrinsztejnInstituto Nacional de Infectologia Evandro Chagas-INI-Fiocruz, Rio de Janeiro, Brazil.
Lisa A MillsCenters for Disease Control and Prevention (CDC) Division of HIV/AIDS Prevention/KEMRI-CDC Research and Public Health Collaboration HIV Research Branch, Kisumu, Kenya.
Joseph MakhemaBotswana Harvard AIDS Institute, Gabarone.
Breno R SantosServico de Infectologia, Hospital Nossa Senhora da Conceicao/GHC, Porto Alegre, Brazil.
Ying Q ChenVaccine and Infectious Disease Science Division, Fred Hutchinson Cancer Research Institute, Seattle, Washington.
Thomas C QuinnLaboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Baltimore, Maryland.
Christophe FraserBig Data Institute, University of Oxford, United Kingdom.
Myron S CohenDepartment of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Susan H EshlemanDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Oliver LaeyendeckerLaboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Baltimore, Maryland.
Johns Hopkins University · USFred Hutch Cancer Center · USJohns Hopkins Medicine · USUniversity of North Carolina at Chapel Hill · USBotswana Harvard AIDS Institute Partnership · BWChiang Mai University · THFundação Oswaldo Cruz · BRHospital Nossa Senhora da Conceição · BRInstituto Evandro Chagas · BRKenya Medical Research Institute · KENational Institutes of Health · USOpen Data Institute · GBUniversity of Malawi · MWUniversity of Oxford · GBUniversity of Zimbabwe · ZWYR Gaitonde Centre for AIDS Research and Education · IN

Funding

LOC: HIV Prevention Trials NetworkUM1AI068619 · NIAID · FAMILY HEALTH INTERNATIONAL · PI MYRON Scott COHEN, Sinead Delany-Moretlwe · 2011 to 2026
$779.5M
SDMC: HPTN 084 Pregnancy SupplementUM1AI068617 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Elizabeth Renata Brown, Deborah J Donnell · 2011 to 2026
$204.9M
LC: HIV Prevention Trials Network - Laboratory Support for the SARS-CoV-2 Seroprevalence Study (CoVPN 5002)UM1AI068613 · NIAID · JOHNS HOPKINS UNIVERSITY · PI SUSAN H ESHLEMAN, Mark A Marzinke · 2011 to 2026
$100.2M
University of North Carolina Global HIV Prevention and Treatment Clinical Trials Unit 2024 SupplementUM1AI069423 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Joseph J Eron, MINA CHRISTINE HOSSEINIPOUR · 2012 to 2026
$71.8M
UCLA AIDS Prevention and Treatment Clinical Trials UnitUM1AI069424 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Judith S. Currier, RAPHAEL J LANDOVITZ · 2012 to 2026
$51.8M
The Malawi Clinical Trials UnitUM1AI069518 · NIAID · JOHNS HOPKINS UNIVERSITY · PI JACKY M JENNINGS, TAHA E TAHA · 2012 to 2026
$43.8M
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit (FioTrials)UM1AI069476 · NIAID · FUNDACAO OSWALDO CRUZ · PI BEATRIZ GRINSZTEJN · 2012 to 2026
$26.3M
International Center for Excellence in Research (ICER) in Uganda: Impact of ARVsZIAAI001040 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI REYNOLDS, STEVEN · 2009 to 2025
$23.5M
International Studies of the Acquired Immune Deficiency Syndrome (AIDS)ZIAAI000361 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI REDD, ANDREW · 2009 to 2025
$15.8M
UCLA AIDS Prevention and Treatment Clinical Trials UnitU01AI069424 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CURRIER, JUDITH S. · 2007 to 2011
$13.9M
FHCRC High-Performance Computing ClusterS10OD020069 · OD · FRED HUTCHINSON CANCER RESEARCH CENTER · PI KOOPERBERG, CHARLES L · 2015 to 2015
$600k
BIOMEDICAL INFORMATION DEVELOPMENT IN SUB-SAHARAN AFRICAD43TW001081 · FIC · JOHNS HOPKINS UNIVERSITY · PI TAHA, TAHA E · 1998 to 2003
$435k
CCR NIH HHS HHSN261200800001CFIC NIH HHS D43 TW001081NCI NIH HHS HHSN261200800001ENIAID NIH HHS U01 AI069424NIAID NIH HHS UM1 AI068613NIAID NIH HHS UM1 AI068617NIAID NIH HHS UM1 AI068619NIAID NIH HHS UM1 AI069423NIAID NIH HHS UM1 AI069424NIAID NIH HHS UM1 AI069476NIAID NIH HHS UM1 AI069518NIH HHS S10 OD020069
6 · The paper itself

Abstract

backgroundWe evaluated use of phylogenetic methods to predict the direction of human immunodeficiency virus (HIV) transmission.

methodsFor 33 pairs of HIV-infected patients (hereafter, "index patients") and their partners who acquired genetically linked HIV infection during the study, samples were collected from partners and index patients close to the time when the partner seroconverted (hereafter, "SC samples"); for 31 pairs, samples collected from the index patient at an earlier time point (hereafter, "early index samples") were also available. Phylogenies were inferred using env next-generation sequences (1 tree per pair/subtype). The direction of transmission (DoT) predicted from each tree was classified as correct or incorrect on the basis of which sequences (those from the index patient or the partner) were closest to the root. DoT was also assessed using maximum parsimony to infer ancestral node states for 100 bootstrap trees.

resultsDoT was predicted correctly for both single-pair and subtype-specific trees in 22 pairs (67%) by using SC samples and in 23 pairs (74%) by using early index samples. DoT was predicted incorrectly for 4 pairs (15%) by using SC or early index samples. In the bootstrap analysis, DoT was predicted correctly for 18 pairs (55%) by using SC samples and for 24 pairs (73%) by using early index samples. DoT was predicted incorrectly for 7 pairs (21%) by using SC samples and for 4 pairs (13%) by using early index samples.

conclusionsPhylogenetic methods based solely on the tree topology of HIV env sequences, particularly without consideration of phylogenetic uncertainty, may be insufficient for determining DoT.

Indexed as

Disease Transmission, InfectiousGenotypePhylogenyCohort Studiesenv Gene Products, Human Immunodeficiency VirusFemaleHeterosexualityHigh-Throughput Nucleotide SequencingHIVHIV InfectionsHumansMaleMolecular Epidemiologyenv Gene Products, Human Immunodeficiency VirusepidemiologyNetworksviral dynamics

Identifiers

PMID30590741
PMCPMC6761953
OpenAlexW2906565734

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.